Skip to main content Accessibility help
×

Temporary Disruption

We have implemented additional assurance measures to protect our systems.

As a result, we have suspended some of our systems and services. We apologise for any temporary disruption some customers may experience.

Hostname: page-component-5d84bcc8dc-8db7n Total loading time: 0 Render date: 2026-09-10T21:22:47.394Z Has data issue: false hasContentIssue false

Chapter 20 - Candidate Biomarkers for Prediction of Pregnancy Location and Viability

Published online by Cambridge University Press:  16 April 2025

By
Kassie J. Bollig  and
Kurt T. Barnhart
Edited by
Roy G. Farquharson ,
Mary D. Stephenson  and
Mariëtte Goddijn
Roy G. Farquharson
Affiliation:
Liverpool Women’s Hospital
Mary D. Stephenson
Affiliation:
University of Illinois, Chicago
Mariëtte Goddijn
Affiliation:
Amsterdam University Medical Centers
Get access

Summary

Accurate discrimination between normal and abnormal early pregnancies remains a clinical challenge. The successful identification and application of novel biomarkers produced during early pregnancy could change the diagnostic standard and improve patient outcomes. The approach to biomarker discovery can involve either putative or agnostic strategies, and for successful clinical implementation, all biomarkers must proceed through five phases of development. Biomarkers for discrimination of early pregnancy include those related to trophoblast function, corpus luteal function, angiogenesis, endometrial function, inflammation and muscle damage, and unknown mechanisms. To date, no single biomarker (other than serial beta human chorionic gonadotropin) is used in clinical practice, reflecting the significant heterogeneity among available studies and unique considerations in specific subgroups with early pregnancy. Panels consisting of multiple biomarkers are likely the most promising approach for successful implementation.

Keywords

ectopic pregnancypregnancy of unknown locationbiomarkerviability

Information

Type
Chapter
Information
Early Pregnancy , pp. 199 - 212
Publisher: Cambridge University Press
Print publication year: 2025

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Hasan, R., Baird, D. D., Herring, A. H., Olshan, A. F., Jonsson Funk, M. L., Hartman, K. E.. Patterns and predictors of vaginal bleeding in the first trimester of pregnancy. Ann Epidemiol. 2010;20(7):524–31.CrossRefGoogle ScholarPubMed
American College of Obstetrics and Gynecologists ACOG practice bulletin no. 191: tubal ectopic pregnancy. Obstet Gynecol. 2018;131:e65–77.CrossRefGoogle Scholar
Creanga, A. A., Syverson, C., Seed, K., Callaghan, W. M.. Pregnancy-related mortality in the United States, 2011–2013. Obstet Gynecol. 2017;130(2):366–73.CrossRefGoogle ScholarPubMed
Barnhart, K. T., Sammel, M. D., Gracia, C. R., Chittams, J., Humel, A. C., Shaunik, A.. Risk factors for ectopic pregnancy in women with symptomatic first-trimester pregnancies. Fertil Steril. 2006;86(1):36–43.CrossRefGoogle ScholarPubMed
Barnhart, K. T., Simhan, H., Kamell, S. A.. Diagnostic accuracy of ultrasound above and below the beta-hCG discriminatory zone. Obstet Gynecol. 1999;94(4):583–87.Google ScholarPubMed
Barnhart, K. T., Sammel, M. D., Rinaudo, P. F., Zhou, L., Hummel, A. C., Guo, W.. Symptomatic patients with an early viable intrauterine pregnancy: hCG curves redefined. Obstet Gynecol. 2004;104(1):50–55.CrossRefGoogle Scholar
Silva, C., Sammel, M. D., Zhou, L., Gracia, C., Hummel, A. C., Barnhart, K.. Human chorionic gonadotropin profile for women with an ectopic pregnancy. Obstet Gynecol. 2006;107(3):605–10.CrossRefGoogle ScholarPubMed
Barnhart, K. T.. Ectopic pregnancy. New Eng J Med. 2009;361(4):379–87.CrossRefGoogle ScholarPubMed
Seeber, B. E., Barnhart, K. T.. Suspected ectopic pregnancy. Obstet Gynecol. 2006;107(2 Part 1):399–413.CrossRefGoogle ScholarPubMed
Morse, C. B., Sammel, M. D., Shaunik, A., Allen-Taylor, L., Oberfoell, N. L., Takacs, P., et al. Performance of human chorionic gonadotropin curves in women at risk for ectopic pregnancy: exceptions to the rules. Fertil Steril. 2012;97(1):101–6.CrossRefGoogle Scholar
Palmer, S. S., Barnhart, K. T.. Biomarkers in reproductive medicine: the promise, and can it be fulfilled? Fertil Steril. 2013;99(4):954–62.CrossRefGoogle ScholarPubMed
Pepe, M. S., Etzioni, R., Feng, A. Z., Potter, J. D., Thompson, M. L., Winget, M., et al. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst. 2001;93(14):1054–61.CrossRefGoogle ScholarPubMed
Barnhart, K. T., Guo, W., Cary, M. S., Morse, C. B., Chung, K., Takacs, P., et al. Differences in serum human chorionic gonadotropin rise in early pregnancy by race and value at presentation. Obstet Gynecol. 2016;128(3):504–11.CrossRefGoogle ScholarPubMed
Barnhart, K. T., Sammel, M. D., Stephenson, M., Robins, J., Hansen, K. R., Youssef, W. A., et al. Optimal treatment for women with a persisting pregnancy of unknown location, a randomized controlled trial: The ACT-or-NOT trial. Contemp Clin Trials. 2018;73:14–51.CrossRefGoogle ScholarPubMed
Condous, G., Lu, C., Van Huffel, S. V., Timmerman, D., Bourne, T.. Human chorionic gonadotrophin and progesterone levels in pregnancies of unknown location. Int J Gynaecol Obstet. 2004;86(3):351.CrossRefGoogle ScholarPubMed
Condous, G., Kirk, E., Van Calster, B., Van Huffel, S., Timmerman, D., Bourne, T.. Failing pregnancies of unknown location: a prospective evaluation of the human chorionic gonadotrophin ratio. BJOG. 2006;113(5):521–27.CrossRefGoogle ScholarPubMed
Kirk, E., Condous, G., Van Calster, B., Van Huffel, S., Timmerman, D., Bourne, T.. Rationalizing the follow-up of pregnancies of unknown location. Hum Reprod. 2007;22(6):1744.CrossRefGoogle ScholarPubMed
Condous, G., Okaro, E., Khalid, A., Timmerman, D., Lu, C., Zhou, Y., et al. The use of a new logistic regression model for predicting the outcome of pregnancies of unknown location. Hum Reprod. 2004;19(8):1900–1910.CrossRefGoogle Scholar
van Mello, N. M., Mol, F., Opmeer, B. C., Ankum, W. M., Barnhart, K., Coomarasamy, A., et al. Diagnostic value of serum hCG on the outcome of pregnancy of unknown location: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(6):603–17.CrossRefGoogle ScholarPubMed
Van Calster, B., Abdallah, Y., Guha, S., Kirk, E., Van Hoorde, K., Condous, G., et al. Rationalizing the management of pregnancies of unknown location: temporal and external validation of a risk prediction model on 1962 pregnancies. Hum Reprod. 2013;28(3):609–16.CrossRefGoogle ScholarPubMed
Barnhart, K. T., Sammel, M. D., Appleby, D., Rausch, M., Molinaro, T., Van Calster, B., et al. Does a prediction model for pregnancy of unknown location developed in the UK validate on a US population? Hum Reprod. 2010;25(10):2434.CrossRefGoogle ScholarPubMed
Van Calster, B., Bobdiwala, S., Guha, S., Van Hoorde, K., Al-Memar, M., Harvey, R., et al. Managing pregnancy of unknown location based on initial serum progesterone and serial serum hCG levels: development and validation of a two-step triage protocol. Ultrasound Obstet Gynecol. 2016;48(5):642–49.CrossRefGoogle ScholarPubMed
Cole, L. A.. Hyperglycosylated hCG, a review. Placenta. 2010;31(8):653–64.CrossRefGoogle ScholarPubMed
Sutton-Riley, J. M., Khanlian, S. A., Byrn, F. W., Cole, L. A.. A single serum test for measuring early pregnancy outcome with high predictive value. Clin Biochem. 2006;39(7):682–87.CrossRefGoogle Scholar
Sasaki, Y., Ladner, D. G., Cole, L. A.. Hyperglycosylated human chorionic gonadotropin and the source of pregnancy failures. Fertil Steril. 2008;89(6):1781–86.CrossRefGoogle ScholarPubMed
Grossman, K., Cordina, M., Ross, J. A.. Is there a role for hyperglycosylated hCG in the diagnosis of ectopic pregnancy in women with a pregnancy of unknown location? J Reprod Med. 2017;62(1–2):15–20.Google Scholar
Chuan, S., Homer, M., Pandian, R., Conway, D., Garzo, G., Yeo, L., et al. Hyperglycosylated human chorionic gonadotropin as an early predictor of pregnancy outcomes after in vitro fertilization. Fertil Steril. 2014;101(2):392–98.CrossRefGoogle Scholar
Bosch, E., Hund, M., , R., Caracena, L., Ahlers, S., Labarta, E.. Early detection of pregnancy after IVF and embryo transfer with hyperglycosylated HCG versus Elecsys HCG+β assay. Reprod Biomed Online. 2022;44(2):349–56.CrossRefGoogle ScholarPubMed
Wolf, G. C., Medford, E. E., Wynn, R. M.. Trophoblast production of hCG and ahCG from normal and abnormal pregnancies. Gynecol Obstet Invest. 1994;37(4):236–41.CrossRefGoogle ScholarPubMed
Borrelli, P. T., Butler, S. A., Docherty, S. M., Staite, E. M., Borrelli, A. L., Iles, R. K.. Human chorionic gonadotropin isoforms in the diagnosis of ectopic pregnancy. Clin Chem. 2003;49(12):2045–49.CrossRefGoogle ScholarPubMed
Bearfield, C., Jauniaux, E., Groome, N., Sargent, I. L., Muttukrishna, S.. The secretion and effect of inhibin A, activin A and follistatin on first-trimester trophoblasts in vitro. Eur J Endocrinol. 2005;152(6):909–16.CrossRefGoogle ScholarPubMed
Florio, P., Severi, F. M., Bocchi, C., Luisi, S., Mazzini, M., Danero, S., et al. Single serum activin a testing to predict ectopic pregnancy. J Clin Endocrinol Metab. 2007;92(5):1748–53.CrossRefGoogle ScholarPubMed
Rausch, M. E., Sammel, M. D., Takacs, P., Chung, K., Shaunik, A., Barnhart, K. T.. Development of a multiple marker test for ectopic pregnancy. Obstet Gynecol. 2011;117(3):573–82.CrossRefGoogle Scholar
Daponte, A., Deligeoroglou, E., Garas, A., Purnaras, S., Hadjichristodoulou, C., Messinis, I. E.. Activin A and follistatin as biomarkers for ectopic pregnancy and missed abortion. Dis Markers. 2013;35(5):497–503.CrossRefGoogle ScholarPubMed
Kirk, E., Papageorghiou, A. T., Van Calster, B., Condous, G., Cowans, N., Van Huffel, S., et al. The use of serum inhibin A and activin A levels in predicting the outcome of “pregnancies of unknown location”. Hum Reprod. 2009;24(10):2451–56.CrossRefGoogle Scholar
Warrick, J., Gronowski, A., Moffett, C., Zhao, Q., Bishop, E., Woodworth, A.. Serum activin A does not predict ectopic pregnancy as a single measurement test, alone or as part of a multi-marker panel including progesterone and hCG. Clin Chim Acta. 2012;413(7–8):707–11.CrossRefGoogle ScholarPubMed
Nicolaides, K. H., Spencer, K., Avgidou, K., Faiola, S., Falcon, O.. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol. 2005;25(3):221–26.CrossRefGoogle Scholar
Wang, J., Liu, S., Qin, H.-M., Zhao, Y., Wang, X.-Q., Yan, Q.. Pregnancy-associated plasma protein A up-regulated by progesterone promotes adhesion and proliferation of trophoblastic cells. Int J Clin Exp Pathol. 2014;7(4):1427–37.Google ScholarPubMed
Dumps, P., Meisser, A., Pons, D., Morales, M. A., Anguenot, J. L., Campana, A., et al. Accuracy of single measurements of pregnancy-associated plasma protein-A, human chorionic gonadotropin and progesterone in the diagnosis of early pregnancy failure. Eur J Obstet Gynecol Reprod Biol. 2002;100(2):174–80.CrossRefGoogle ScholarPubMed
Ugurlu, E. N., Ozaksit, G., Karaer, A., Zulfikaroglu, E., Atalay, A., Ugur, M.. The value of vascular endothelial growth factor, pregnancy-associated plasma protein-A, and progesterone for early differentiation of ectopic pregnancies, normal intrauterine pregnancies, and spontaneous miscarriages. Fertil Steril. 2009;91(5):1657–61.CrossRefGoogle ScholarPubMed
Zhang, X., Wang, C.. Predictive value of PAPP-A for ectopic pregnancy and analysis of related factors. Exp Ther Med. 2021;22(2):801.CrossRefGoogle Scholar
Daponte, A., Pournaras, S., Zintzaras, E., Kallitsaris, A., Lialios, G., Maniatis, A. N., et al. The value of a single combined measurement of VEGF, glycodelin, progesterone, PAPP-A, HPL and LIF for differentiating between ectopic and abnormal intrauterine pregnancy. Hum Reprod. 2005;20(11):3163–66.CrossRefGoogle ScholarPubMed
Mueller, M. D., Raio, L., Spoerri, S., Ghezzi, F., Dreher, E., Bersinger, N. A.. Novel placental and nonplacental serum markers in ectopic versus normal intrauterine pregnancy. Fertil Steril. 2004;81(4):1106–11.CrossRefGoogle ScholarPubMed
Senapati, S., Sammel, M. D., Butts, S. F., Takacs, P., Chung, K., Barnhard, K. T.. Predicting first trimester pregnancy outcome: derivation of a multiple marker test. Fertil Steril. 2016;106(7):1725–32.CrossRefGoogle ScholarPubMed
Horne, C. H., Towler, C. M., Pugh-Humphreys, R. G., Thompson, A. W., Bohn, H.. Pregnancy specific beta1-glycoprotein – a product of the syncytiotrophoblast. Experientia. 1976;32(9):1197.CrossRefGoogle ScholarPubMed
Earl, U., Wells, M., Bulmer, J. N.. Immunohistochemical characterisation of trophoblast antigens and secretory products in ectopic tubal pregnancy. Int J Gynecol Pathol. 1986;5(2):132–42.CrossRefGoogle ScholarPubMed
Beer, L. A., Tang, H.-Y., Sriswasdi, S., Barnhart, K. T., Speicher, D. W.. Systematic discovery of ectopic pregnancy serum biomarkers using 3-D protein profiling coupled with label-free quantitation. J Proteome Res. 2011;10(3):1126–38.CrossRefGoogle ScholarPubMed
Ho, P. C., Jones, W. R.. Pregnancy-specific beta 1-glycoprotein as a prognostic indicator in complications of early pregnancy. Am J Obstet Gynecol. 1980;138(3):253–56.CrossRefGoogle ScholarPubMed
Kauppila, A., Rantakylä, P., Huhtaniemi, I., Ylikorkala, O., Seppälä, M.. Trophoblastic markers in the differential diagnosis of ectopic pregnancy. Obstet Gynecol. 1980;55(5):560–64.Google ScholarPubMed
Witt, B. R., Wolf, G. C., Wainwright, C. J., Johnston, P. D., Thorneycroft, I. H.. Relaxin, CA-125, progesterone, estradiol, Schwangerschaft protein, and human chorionic gonadotropin as predictors of outcome in threatened and non-threatened pregnancies. Fertil Steril. 1990;53(6):1029–36.CrossRefGoogle Scholar
Tong, S., Marjono, B., Brown, D. A., Mulvey, S., Breit, S. N., Manuelpillai, U., et al. Serum concentrations of macrophage inhibitory cytokine 1 (MIC 1) as a predictor of miscarriage. Lancet. 2004;363(9403):129–30.CrossRefGoogle ScholarPubMed
Skubisz, M. M., Brown, J. K., Tong, S., Kaitu’u-Lino, T., Horne, A. W.. Maternal serum macrophage inhibitory cytokine-1 as a biomarker for ectopic pregnancy in women with a pregnancy of unknown location. PLoS One. 2013;8(6):e66339.CrossRefGoogle ScholarPubMed
Walker, W. H., Fitzpatrick, S. L., Barrera-Saldaña, H. A., Resendez-Perez, D., Saunders, G. F.. The human placental lactogen genes: structure, function, evolution and transcriptional regulation. Endocrine Reviews. 1991;12(4):316–28.CrossRefGoogle ScholarPubMed
Huppertz, B., Bartz, C., Kokozidou, M.. Trophoblast fusion: fusogenic proteins, syncytins and ADAMs, and other prerequisites for syncytial fusion. Micron. 2006;37(6):509–17.CrossRefGoogle Scholar
Zou, S., Li, X., Feng, Y., Sun, S., Li, J., Egecioglu, E., et al. Comparison of the diagnostic values of circulating steroid hormones, VEGF-A, PIGF, and ADAM12 in women with ectopic pregnancy. J Transl Med. 2013;11:44.CrossRefGoogle ScholarPubMed
Horne, A. W., Brown, J. K., Tong, S., Kaitu’u-Lino, T.. Evaluation of ADAM-12 as a diagnostic biomarker of ectopic pregnancy in women with a pregnancy of unknown location. PLoS One. 2012;7(8):e41442.CrossRefGoogle ScholarPubMed
Yang, J., Wu, J., Guo, F., Wang, D., Chen, K., Li, J., et al. Maternal serum disintegrin and metalloprotease protein-12 in early pregnancy as a potential marker of adverse pregnancy outcomes. PLoS One. 2014;9(5):e97284.CrossRefGoogle ScholarPubMed
Takacs, P., Jaramillo, S., Datar, R., Williams, A., Olczyk, J., Barnhart, K.. Placental mRNA in maternal plasma as a predictor of ectopic pregnancy. Int J Gynaecol Obstet. 2012;117(2):131–33.CrossRefGoogle ScholarPubMed
Zhao, Z., Zhao, Q., Warrick, J., Lockwood, C. M., Woodworth, A., Moley, K. H., et al. Circulating microRNA miR-323-3p as a biomarker of ectopic pregnancy. Clin Chem. 2012;58(5):896–905.CrossRefGoogle ScholarPubMed
Miura, K., Higashijima, A., Mishim, H.H, Kitjima, M, Kaneuchi, M., Yoshiura, K.-I., et al. Pregnancy-associated microRNAs in plasma as potential molecular markers of ectopic pregnancy. Fertil Steril. 2015;103(5):1202–28.CrossRefGoogle ScholarPubMed
Dominguez, F., Moreno-Moya, J. M., Lozoya, T., Romero, A., Martínez, A., Monterde, M., et al. Embryonic miRNA profiles of normal and ectopic pregnancies. PLoS One. 2014;9(7):e102185.CrossRefGoogle ScholarPubMed
Lu, Q., Yan, Qi., Xu, F., Li, Y., Zhao, W., Wu, C., et al. MicroRNA-873 is a potential serum biomarker for the detection of ectopic pregnancy. Cellular Physiol Biochem. 2017;41(6):2513–22.CrossRefGoogle ScholarPubMed
Stovall, T. G., Ling, F. W., Andersen, R. N., Buster, J. E.. Improved sensitivity and specificity of a single measurement of serum progesterone over serial quantitative beta-human chorionic gonadotrophin in screening for ectopic pregnancy. Hum Reprod. 1992;7(5):723–75.CrossRefGoogle ScholarPubMed
Stern, J. J., Voss, F., Coulam, C. B.. Early diagnosis of ectopic pregnancy using receiver-operator characteristic curves of serum progesterone concentrations. Hum Reprod. 1993;8(5):775–79.CrossRefGoogle ScholarPubMed
Verhaegen, J., Gallos, I. D., van Mello, N. M., Abdel-Azizi, M., Takwoingi, Y., Herb, H., et al. Accuracy of single progesterone test to predict early pregnancy outcome in women with pain or bleeding: meta-analysis of cohort studies. BMJ. 2012;345:e6077.CrossRefGoogle ScholarPubMed
Mol, B. W., Lijmer, J. G., Ankum, W. M., van der Veen, F., Bossuyt, P. M.. The accuracy of single serum progesterone measurement in the diagnosis of ectopic pregnancy: a meta-analysis. Hum Reprod. 1998;13(11):3220–27.CrossRefGoogle ScholarPubMed
Segal, S., Gor, H., Correa, N., Mercado, R., Veenstra, K., Rivnay, B.. Inhibin A: marker for diagnosis of ectopic and early abnormal pregnancies. Reprod Biomed Online. 2008;17(6):789–94.CrossRefGoogle ScholarPubMed
Chetty, M., Sawyer, E., Dew, T., Chapman, A. J., Elson, J.. The use of novel biochemical markers in predicting spontaneously resolving “pregnancies of unknown location.” Hum Reprod. 2011;26(6):1318–23.CrossRefGoogle Scholar
Daniel, Y., Geva, E., Lerner-Geva, L., Eshed-Englender, T., Gamzu, R., Lessing, J. B., et al. Levels of vascular endothelial growth factor are elevated in patients with ectopic pregnancy: is this a novel marker? Fertil Steril. 1999;72(6):1013–17.CrossRefGoogle Scholar
Felemban, A., Sammour, A., Tulandi, T.. Serum vascular endothelial growth factor as a possible marker for early ectopic pregnancy. Hum Reprod. 2002;17(2):490–92.CrossRefGoogle ScholarPubMed
Selvarajan, S., Ramalingam, J., Vijayaraghavan, J., Bobby, Z.. Serum soluble FMS-like tyrosine kinase-1 in ectopic pregnancy. J Lab Physicians. 2019;11(4):335–39.Google ScholarPubMed
Daponte, A., Pournaras, S., Polyzos, N. P., Tsezou, A., Skentou, H., Anastasiadou, F., et al. Soluble FMS-like tyrosine kinase-1 (sFlt-1) and serum placental growth factor (PlGF) as biomarkers for ectopic pregnancy and missed abortion. J Clin Endocrinol Metab. 2011;96(6):E1444–51.CrossRefGoogle ScholarPubMed
Martínez-Ruiz, A., Sarabia-Meseguer, M. D., Pérez-Fornieles, J., Vílchez, J. A., Tovar-Zapata, I., Noguera-Velasco, J. A.. Placental growth factor, soluble fms-like tyrosine kinase 1 and progesterone as diagnostic biomarkers for ectopic pregnancy and missed abortion. Clin Biochem. 2014;47(9):844–47.CrossRefGoogle ScholarPubMed
Horne, A. W., Shaw, J. L., Murdoch, A., McDonald, S. E., Williams, A. R., Jabbour, H. N., et al. Placental growth factor: a promising diagnostic biomarker for tubal ectopic pregnancy. J Clin Endocrinol Metab. 2011;96(1):E104–8.CrossRefGoogle Scholar
Senturk, L. M., Arici, A.. Leukemia inhibitory factor in human reproduction. Am J Reprod Immunol. 1998;39(2):144–51.CrossRefGoogle ScholarPubMed
Wegner, N. T., Mershon, J. L.. Evaluation of leukemia inhibitory factor as a marker of ectopic pregnancy. Am J Obstet Gynecol. 2001(6);184:1074–76.CrossRefGoogle ScholarPubMed
Kiran, G., Kiran, H., Ertopcu, K., Kilinc, M., Ekerbicer, H. C., Varder, M. A.. Tubal uterine leukemia inhibitory factor concentration does not increase in tubal pregnancy: a preliminary study. Fertil Steril. 2005;83:484–86.CrossRefGoogle Scholar
Iyibozkurt, A. C., Kalelioğlu, I., Gursoy, S., Gurepolat, N., Karagan, G. E., Saygili, H., et al. Evaluation of serum levels of interleukin-10, interleukin-11 and leukemia inhibitory factor in differentiation of eutopic and tubal ectopic pregnancies. Clin Exp Obstet Gynecol. 2010;37(3):217–20.Google ScholarPubMed
Foth, D., Römer, T.. Glycodelin serum levels in women with ectopic pregnancy. Eur J Obstet Gynecol Reprod Biol. 2003;108(2):199–202.CrossRefGoogle ScholarPubMed
Soriano, D., Hugol, D., Quang, N. T., Darai, E.. Serum concentrations of interleukin-2R (IL-2R), IL-6, IL-8, and tumor necrosis factor alpha in patients with ectopic pregnancy. Fertil Steril. 2003;79(4):975–80.CrossRefGoogle ScholarPubMed
Daponte, A., Deligeoroglou, E., Pournaras, S., Pournaras, C., Hadjichristodoulou, C., Garas, A., et al. Interleukin-15 (IL-15) and anti-C1q antibodies as serum biomarkers for ectopic pregnancy and missed abortion. Clin Dev Immunol. 2013;2013:637513.CrossRefGoogle ScholarPubMed
Sadovsky, Y., Pineda, J., Collins, J. L.. Serum CA-125 levels in women with ectopic and intrauterine pregnancies. J Reprod Med. 1991;36(12):875–78.Google ScholarPubMed
Brumsted, J. R., Nakajima, S. T., Badger, G., Riddick, D. H., Gibson, M.. Serum concentration of CA-125 during the first trimester of normal and abnormal pregnancies. J Reprod Med. 1990;35(5):499–502.Google ScholarPubMed
Condous, G., Kirk, E., Syed, A., Van Calster, B., Van Huffel, S., Timmerman, D., et al. Do levels of serum cancer antigen 125 and creatine kinase predict the outcome in pregnancies of unknown location? Hum Reprod. 2005;20(12):3348–54.CrossRefGoogle ScholarPubMed
Kuscu, E., Vicdan, K., Turhan, N. O., Oğuz, S., Zorlu, G., Gökmen, O.. The hormonal profile in ectopic pregnancies. Mater Med Pol. 1993;25(3–4):149–52.Google ScholarPubMed
Schmidt, T., Rein, D. T., Foth, D., Eibach, H. W., Kurbacher, C. M., Mallmann, P., et al. Prognostic value of repeated serum CA 125 measurements in first trimester pregnancy. Eur J Obstet Gynecol Reprod Biol. 2001;97(2):168–73.CrossRefGoogle ScholarPubMed
Birkhahn, R. H., Gaeta, T. J., Leo, P. J., Bove, J. J.. The utility of maternal creatine kinase in the evaluation of ectopic pregnancy. Am J Emerg Med. 2000;18(6):695–97.CrossRefGoogle ScholarPubMed
Duncan, W. C., Sweeting, V. M., Cawood, P., Illingworth, P. J.. Measurement of creatine kinase activity and diagnosis of ectopic pregnancy. Br J Obstet Gynaecol. 1995;102(3):233–37.CrossRefGoogle ScholarPubMed
Lavie, O., Beller, U., Neuman, M., Ben-Chetrit, A., Gottcshalk-Sabag, S., Diamant, Y. Z.. Maternal serum creatine kinase: a possible predictor of tubal pregnancy. Am J Obstet Gynecol. 1993;169(5):1149–50.CrossRefGoogle ScholarPubMed
Darai, E., Vlastos, G., Benifla, J. L., Sitbon, D., Hassid, J., Dehoux, M., et al. Is maternal serum creatine kinase actually a marker for early diagnosis of ectopic pregnancy? Eur J Obstet Gynecol Reprod Biol. 1996;68(1–2):25–27.CrossRefGoogle ScholarPubMed
Korhonen, J., Alfthan, H., Stenman, U. H., Ylöstalo, P.. Failure of creatine kinase to predict ectopic pregnancy. Fertil Steril. 1996;65(5):922–24.CrossRefGoogle ScholarPubMed
Lincoln, S. R., Dockery, J. R., Long, C. A., Rock, W. A., Cowan, B. D.. Maternal serum creatine kinase does not predict tubal pregnancy. J Assist Reprod Genet. 1996;13(9):702–4.CrossRefGoogle Scholar
Plewa, M.C., Ledrick, D., Buderer, N. F., King, R. W.. Serum creatine kinase is an unreliable predictor of ectopic pregnancy. Acad Emerg Med. 1998;5(4):300–303.CrossRefGoogle Scholar
Vandermolen, D. T., Borzelleca, J. F.. Serum creatine kinase does not predict ectopic pregnancy. Fertil Steril. 1996;65(5):916–21.CrossRefGoogle Scholar
Birkhahn, R. H., Gaeta, T. J., Paraschiv, D., Bove, J. J., Suzuki, T., Katoh, H., et al. Serum levels of myoglobin, creatine phosphokinase, and smooth muscle heavy-chain myosin in patients with ectopic pregnancy. Ann Emerg Med. 2001;38(6):628–32.CrossRefGoogle ScholarPubMed
Echan, L. A., Tang, H.-Y., Ali-Khan, N., Lee, K., Speicher, D. W.. Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma. Proteomics. 2005;5(13):3292–303.CrossRefGoogle ScholarPubMed
Boschetti, E., Righetti, P. G.. The ProteoMiner in the proteomic arena: a non-depleting tool for discovering low-abundance species. J Proteomics. 2008;71(3):255–64.CrossRefGoogle Scholar
Rausch, M. E., Beer, L., Sammel, M. D., Takacs, P., Chung, K., Shaunik, A., et al. A disintegrin and metalloprotease protein-12 as a novel marker for the diagnosis of ectopic pregnancy. Fertil Steril. 2011;95(4):1373–78.CrossRefGoogle ScholarPubMed
Bollig, K. J., Senapati, S., Sammel, M. D., Takacs, P., Robins, J. C., Haisenleder, D. J., et al. Validation of a multiple marker test for early pregnancy outcome prediction. J Assist Reprod Genet. 2023;40(4):837–44.CrossRefGoogle ScholarPubMed
Sun, J., Deng, G., Ruan, X., Chen, S., Liao, H., Liu, X., et al. Exosomal microRNAs in serum as potential biomarkers for ectopic pregnancy. Biomed Res Int. 2020;2020:3521859.CrossRefGoogle ScholarPubMed
Drucker, E., Krapfenbauer, K.. Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine. EPMA J. 2013;4(1):7.CrossRefGoogle ScholarPubMed
Forest, J.-C., Charland, M., Massé, J., Bujold, E., Rousseau, F., Lafond, J., et al. Candidate biochemical markers for screening of pre-eclampsia in early pregnancy. Clin Chem Lab Med. 2012;50(6):973–84.CrossRefGoogle ScholarPubMed
Sakuragi, N., Ohkubo, H., Yamamoto, R., Shiina, Y., Tanaka, T., Ichinoe, K., et al. The serum pregnancy-specific b1 -glycoprotein to beta-human chorionic gonadotropin ratio as an index of prognosis in patients with choriocarcinoma. Br J Obstet Gynaecol. 1988;95(6):614–18.CrossRefGoogle Scholar

Accessibility standard: Unknown

Why this information is here

This section outlines the accessibility features of this content - including support for screen readers, full keyboard navigation and high-contrast display options. This may not be relevant for you.

Accessibility Information

Accessibility compliance for the HTML of this chapter is currently unknown and may be updated in the future.

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×